Home1734 • TPE
add
Sinphar Pharmaceutical Co Ltd
Previous close
$30.60
Day range
$30.50 - $30.75
Year range
$25.95 - $32.19
Market cap
5.82B TWD
Avg Volume
213.80K
P/E ratio
17.92
Dividend yield
3.11%
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 812.98M | 5.67% |
Operating expense | 245.85M | 11.83% |
Net income | 68.06M | 4.81% |
Net profit margin | 8.37 | -0.83% |
Earnings per share | — | — |
EBITDA | 159.39M | 15.11% |
Effective tax rate | 18.49% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.02B | -7.51% |
Total assets | 6.11B | -4.61% |
Total liabilities | 2.65B | -11.34% |
Total equity | 3.46B | — |
Shares outstanding | 190.20M | — |
Price to book | 1.82 | — |
Return on assets | 4.05% | — |
Return on capital | 4.74% | — |
Cash Flow
Net change in cash
(TWD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 68.06M | 4.81% |
Cash from operations | 116.84M | -20.22% |
Cash from investing | -6.92M | 93.39% |
Cash from financing | -142.97M | -1,182.36% |
Net change in cash | -72.42M | -318.66% |
Free cash flow | 234.10M | 3.42% |
About
Founded
1977
Headquarters
Website
Employees
984